Viewing Study NCT05966233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:07 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
Study NCT ID: NCT05966233
Status: WITHDRAWN
Last Update Posted: 2024-05-21
First Post: 2023-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B Cell Lymphoma Refractory View
None Diffuse Large B-cell Lymphoma Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Diffuse Large B cell Lymphoma View
None Immunochemotherapy View
None DLBCL View
None Autologous View
None Transplant View
None Relapsed View
None Refractory View
None DHAP View
None Rituximab View
None Polatuzumab Vedotin View
None Randomized View
None R-DHAP View
None CD79 View
None PET View
None Review View